Stable Cell Line Development Market, Global Outlook and Forecast 2022-2028

April 2022 | 61 pages | ID: S1E640EDC6FFEN
Market Monitor Global

Abstracts

Stable cell line development is services that cover most of the cell cultures. It is primarily used in research applications and selective diagnosis, the applications involved in stable cell line development covers recombinant protein and antibody production, functional studies, drug screening, gene editing, assay development, and many other platforms.

This report contains market size and forecasts of Stable Cell Line Development in Global, including the following market information:

Global Stable Cell Line Development Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Stable Cell Line Development market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Recombinant Cell Line Development Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Stable Cell Line Development include Genscript Biotech, Molecular Devices, Thermo Fisher Scientific, ProteoGenix, Sino Biological, OriGene Technologies, Fusion Antibodies, GeneCopoeia and BPS Bioscience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Stable Cell Line Development companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Stable Cell Line Development Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Stable Cell Line Development Market Segment Percentages, by Type, 2021 (%)

• Recombinant Cell Line Development
• Continuous Cell Line Development
• Primary Cell Line Development

Global Stable Cell Line Development Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Stable Cell Line Development Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Research Laboratory
• Others

Global Stable Cell Line Development Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Stable Cell Line Development Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Stable Cell Line Development revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Stable Cell Line Development revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Genscript Biotech
• Molecular Devices
• Thermo Fisher Scientific
• ProteoGenix
• Sino Biological
• OriGene Technologies
• Fusion Antibodies
• GeneCopoeia
• BPS Bioscience
• Creative Biomart
• InVivo BioTech
• Creative Biolabs
• Creative Biogene

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Stable Cell Line Development Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Stable Cell Line Development Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL STABLE CELL LINE DEVELOPMENT OVERALL MARKET SIZE

2.1 Global Stable Cell Line Development Market Size: 2021 VS 2028
2.2 Global Stable Cell Line Development Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Stable Cell Line Development Players in Global Market
3.2 Top Global Stable Cell Line Development Companies Ranked by Revenue
3.3 Global Stable Cell Line Development Revenue by Companies
3.4 Top 3 and Top 5 Stable Cell Line Development Companies in Global Market, by Revenue in 2021
3.5 Global Companies Stable Cell Line Development Product Type
3.6 Tier 1, Tier 2 and Tier 3 Stable Cell Line Development Players in Global Market
  3.6.1 List of Global Tier 1 Stable Cell Line Development Companies
  3.6.2 List of Global Tier 2 and Tier 3 Stable Cell Line Development Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Stable Cell Line Development Market Size Markets, 2021 & 2028
  4.1.2 Recombinant Cell Line Development
  4.1.3 Continuous Cell Line Development
  4.1.4 Primary Cell Line Development
4.2 By Type - Global Stable Cell Line Development Revenue & Forecasts
  4.2.1 By Type - Global Stable Cell Line Development Revenue, 2017-2022
  4.2.2 By Type - Global Stable Cell Line Development Revenue, 2023-2028
  4.2.3 By Type - Global Stable Cell Line Development Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Stable Cell Line Development Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Research Laboratory
  5.1.4 Others
5.2 By Application - Global Stable Cell Line Development Revenue & Forecasts
  5.2.1 By Application - Global Stable Cell Line Development Revenue, 2017-2022
  5.2.2 By Application - Global Stable Cell Line Development Revenue, 2023-2028
  5.2.3 By Application - Global Stable Cell Line Development Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Stable Cell Line Development Market Size, 2021 & 2028
6.2 By Region - Global Stable Cell Line Development Revenue & Forecasts
  6.2.1 By Region - Global Stable Cell Line Development Revenue, 2017-2022
  6.2.2 By Region - Global Stable Cell Line Development Revenue, 2023-2028
  6.2.3 By Region - Global Stable Cell Line Development Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Stable Cell Line Development Revenue, 2017-2028
  6.3.2 US Stable Cell Line Development Market Size, 2017-2028
  6.3.3 Canada Stable Cell Line Development Market Size, 2017-2028
  6.3.4 Mexico Stable Cell Line Development Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Stable Cell Line Development Revenue, 2017-2028
  6.4.2 Germany Stable Cell Line Development Market Size, 2017-2028
  6.4.3 France Stable Cell Line Development Market Size, 2017-2028
  6.4.4 U.K. Stable Cell Line Development Market Size, 2017-2028
  6.4.5 Italy Stable Cell Line Development Market Size, 2017-2028
  6.4.6 Russia Stable Cell Line Development Market Size, 2017-2028
  6.4.7 Nordic Countries Stable Cell Line Development Market Size, 2017-2028
  6.4.8 Benelux Stable Cell Line Development Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Stable Cell Line Development Revenue, 2017-2028
  6.5.2 China Stable Cell Line Development Market Size, 2017-2028
  6.5.3 Japan Stable Cell Line Development Market Size, 2017-2028
  6.5.4 South Korea Stable Cell Line Development Market Size, 2017-2028
  6.5.5 Southeast Asia Stable Cell Line Development Market Size, 2017-2028
  6.5.6 India Stable Cell Line Development Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Stable Cell Line Development Revenue, 2017-2028
  6.6.2 Brazil Stable Cell Line Development Market Size, 2017-2028
  6.6.3 Argentina Stable Cell Line Development Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Stable Cell Line Development Revenue, 2017-2028
  6.7.2 Turkey Stable Cell Line Development Market Size, 2017-2028
  6.7.3 Israel Stable Cell Line Development Market Size, 2017-2028
  6.7.4 Saudi Arabia Stable Cell Line Development Market Size, 2017-2028
  6.7.5 UAE Stable Cell Line Development Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Genscript Biotech
  7.1.1 Genscript Biotech Corporate Summary
  7.1.2 Genscript Biotech Business Overview
  7.1.3 Genscript Biotech Stable Cell Line Development Major Product Offerings
  7.1.4 Genscript Biotech Stable Cell Line Development Revenue in Global Market (2017-2022)
  7.1.5 Genscript Biotech Key News
7.2 Molecular Devices
  7.2.1 Molecular Devices Corporate Summary
  7.2.2 Molecular Devices Business Overview
  7.2.3 Molecular Devices Stable Cell Line Development Major Product Offerings
  7.2.4 Molecular Devices Stable Cell Line Development Revenue in Global Market (2017-2022)
  7.2.5 Molecular Devices Key News
7.3 Thermo Fisher Scientific
  7.3.1 Thermo Fisher Scientific Corporate Summary
  7.3.2 Thermo Fisher Scientific Business Overview
  7.3.3 Thermo Fisher Scientific Stable Cell Line Development Major Product Offerings
  7.3.4 Thermo Fisher Scientific Stable Cell Line Development Revenue in Global Market (2017-2022)
  7.3.5 Thermo Fisher Scientific Key News
7.4 ProteoGenix
  7.4.1 ProteoGenix Corporate Summary
  7.4.2 ProteoGenix Business Overview
  7.4.3 ProteoGenix Stable Cell Line Development Major Product Offerings
  7.4.4 ProteoGenix Stable Cell Line Development Revenue in Global Market (2017-2022)
  7.4.5 ProteoGenix Key News
7.5 Sino Biological
  7.5.1 Sino Biological Corporate Summary
  7.5.2 Sino Biological Business Overview
  7.5.3 Sino Biological Stable Cell Line Development Major Product Offerings
  7.5.4 Sino Biological Stable Cell Line Development Revenue in Global Market (2017-2022)
  7.5.5 Sino Biological Key News
7.6 OriGene Technologies
  7.6.1 OriGene Technologies Corporate Summary
  7.6.2 OriGene Technologies Business Overview
  7.6.3 OriGene Technologies Stable Cell Line Development Major Product Offerings
  7.6.4 OriGene Technologies Stable Cell Line Development Revenue in Global Market (2017-2022)
  7.6.5 OriGene Technologies Key News
7.7 Fusion Antibodies
  7.7.1 Fusion Antibodies Corporate Summary
  7.7.2 Fusion Antibodies Business Overview
  7.7.3 Fusion Antibodies Stable Cell Line Development Major Product Offerings
  7.7.4 Fusion Antibodies Stable Cell Line Development Revenue in Global Market (2017-2022)
  7.7.5 Fusion Antibodies Key News
7.8 GeneCopoeia
  7.8.1 GeneCopoeia Corporate Summary
  7.8.2 GeneCopoeia Business Overview
  7.8.3 GeneCopoeia Stable Cell Line Development Major Product Offerings
  7.8.4 GeneCopoeia Stable Cell Line Development Revenue in Global Market (2017-2022)
  7.8.5 GeneCopoeia Key News
7.9 BPS Bioscience
  7.9.1 BPS Bioscience Corporate Summary
  7.9.2 BPS Bioscience Business Overview
  7.9.3 BPS Bioscience Stable Cell Line Development Major Product Offerings
  7.9.4 BPS Bioscience Stable Cell Line Development Revenue in Global Market (2017-2022)
  7.9.5 BPS Bioscience Key News
7.10 Creative Biomart
  7.10.1 Creative Biomart Corporate Summary
  7.10.2 Creative Biomart Business Overview
  7.10.3 Creative Biomart Stable Cell Line Development Major Product Offerings
  7.10.4 Creative Biomart Stable Cell Line Development Revenue in Global Market (2017-2022)
  7.10.5 Creative Biomart Key News
7.11 InVivo BioTech
  7.11.1 InVivo BioTech Corporate Summary
  7.11.2 InVivo BioTech Business Overview
  7.11.3 InVivo BioTech Stable Cell Line Development Major Product Offerings
  7.11.4 InVivo BioTech Stable Cell Line Development Revenue in Global Market (2017-2022)
  7.11.5 InVivo BioTech Key News
7.12 Creative Biolabs
  7.12.1 Creative Biolabs Corporate Summary
  7.12.2 Creative Biolabs Business Overview
  7.12.3 Creative Biolabs Stable Cell Line Development Major Product Offerings
  7.12.4 Creative Biolabs Stable Cell Line Development Revenue in Global Market (2017-2022)
  7.12.5 Creative Biolabs Key News
7.13 Creative Biogene
  7.13.1 Creative Biogene Corporate Summary
  7.13.2 Creative Biogene Business Overview
  7.13.3 Creative Biogene Stable Cell Line Development Major Product Offerings
  7.13.4 Creative Biogene Stable Cell Line Development Revenue in Global Market (2017-2022)
  7.13.5 Creative Biogene Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Stable Cell Line Development Market Opportunities & Trends in Global Market
Table 2. Stable Cell Line Development Market Drivers in Global Market
Table 3. Stable Cell Line Development Market Restraints in Global Market
Table 4. Key Players of Stable Cell Line Development in Global Market
Table 5. Top Stable Cell Line Development Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Stable Cell Line Development Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Stable Cell Line Development Revenue Share by Companies, 2017-2022
Table 8. Global Companies Stable Cell Line Development Product Type
Table 9. List of Global Tier 1 Stable Cell Line Development Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Stable Cell Line Development Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Stable Cell Line Development Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Stable Cell Line Development Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Stable Cell Line Development Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Stable Cell Line Development Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Stable Cell Line Development Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Stable Cell Line Development Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Stable Cell Line Development Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Stable Cell Line Development Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Stable Cell Line Development Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Stable Cell Line Development Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Stable Cell Line Development Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Stable Cell Line Development Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Stable Cell Line Development Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Stable Cell Line Development Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Stable Cell Line Development Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Stable Cell Line Development Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Stable Cell Line Development Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Stable Cell Line Development Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Stable Cell Line Development Revenue, (US$, Mn), 2023-2028
Table 30. Genscript Biotech Corporate Summary
Table 31. Genscript Biotech Stable Cell Line Development Product Offerings
Table 32. Genscript Biotech Stable Cell Line Development Revenue (US$, Mn), (2017-2022)
Table 33. Molecular Devices Corporate Summary
Table 34. Molecular Devices Stable Cell Line Development Product Offerings
Table 35. Molecular Devices Stable Cell Line Development Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific Stable Cell Line Development Product Offerings
Table 38. Thermo Fisher Scientific Stable Cell Line Development Revenue (US$, Mn), (2017-2022)
Table 39. ProteoGenix Corporate Summary
Table 40. ProteoGenix Stable Cell Line Development Product Offerings
Table 41. ProteoGenix Stable Cell Line Development Revenue (US$, Mn), (2017-2022)
Table 42. Sino Biological Corporate Summary
Table 43. Sino Biological Stable Cell Line Development Product Offerings
Table 44. Sino Biological Stable Cell Line Development Revenue (US$, Mn), (2017-2022)
Table 45. OriGene Technologies Corporate Summary
Table 46. OriGene Technologies Stable Cell Line Development Product Offerings
Table 47. OriGene Technologies Stable Cell Line Development Revenue (US$, Mn), (2017-2022)
Table 48. Fusion Antibodies Corporate Summary
Table 49. Fusion Antibodies Stable Cell Line Development Product Offerings
Table 50. Fusion Antibodies Stable Cell Line Development Revenue (US$, Mn), (2017-2022)
Table 51. GeneCopoeia Corporate Summary
Table 52. GeneCopoeia Stable Cell Line Development Product Offerings
Table 53. GeneCopoeia Stable Cell Line Development Revenue (US$, Mn), (2017-2022)
Table 54. BPS Bioscience Corporate Summary
Table 55. BPS Bioscience Stable Cell Line Development Product Offerings
Table 56. BPS Bioscience Stable Cell Line Development Revenue (US$, Mn), (2017-2022)
Table 57. Creative Biomart Corporate Summary
Table 58. Creative Biomart Stable Cell Line Development Product Offerings
Table 59. Creative Biomart Stable Cell Line Development Revenue (US$, Mn), (2017-2022)
Table 60. InVivo BioTech Corporate Summary
Table 61. InVivo BioTech Stable Cell Line Development Product Offerings
Table 62. InVivo BioTech Stable Cell Line Development Revenue (US$, Mn), (2017-2022)
Table 63. Creative Biolabs Corporate Summary
Table 64. Creative Biolabs Stable Cell Line Development Product Offerings
Table 65. Creative Biolabs Stable Cell Line Development Revenue (US$, Mn), (2017-2022)
Table 66. Creative Biogene Corporate Summary
Table 67. Creative Biogene Stable Cell Line Development Product Offerings
Table 68. Creative Biogene Stable Cell Line Development Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Stable Cell Line Development Segment by Type in 2021
Figure 2. Stable Cell Line Development Segment by Application in 2021
Figure 3. Global Stable Cell Line Development Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Stable Cell Line Development Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Stable Cell Line Development Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Stable Cell Line Development Revenue in 2021
Figure 8. By Type - Global Stable Cell Line Development Revenue Market Share, 2017-2028
Figure 9. By Application - Global Stable Cell Line Development Revenue Market Share, 2017-2028
Figure 10. By Region - Global Stable Cell Line Development Revenue Market Share, 2017-2028
Figure 11. By Country - North America Stable Cell Line Development Revenue Market Share, 2017-2028
Figure 12. US Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Stable Cell Line Development Revenue Market Share, 2017-2028
Figure 16. Germany Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 17. France Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Stable Cell Line Development Revenue Market Share, 2017-2028
Figure 24. China Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 28. India Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Stable Cell Line Development Revenue Market Share, 2017-2028
Figure 30. Brazil Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Stable Cell Line Development Revenue Market Share, 2017-2028
Figure 33. Turkey Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Stable Cell Line Development Revenue, (US$, Mn), 2017-2028
Figure 37. Genscript Biotech Stable Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Molecular Devices Stable Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Stable Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ProteoGenix Stable Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sino Biological Stable Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. OriGene Technologies Stable Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Fusion Antibodies Stable Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GeneCopoeia Stable Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BPS Bioscience Stable Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Creative Biomart Stable Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. InVivo BioTech Stable Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Creative Biolabs Stable Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Creative Biogene Stable Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)